Reviva Pharmaceuticals Holdings, Inc. (RVPH)

RVPH Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	19.89	14.44	13.48	23.37	18.52	29.69
Cash & Short-Term Investments	19.89	14.44	13.48	23.37	18.52	29.69
Cash Growth	91.92%	7.14%	-42.33%	26.17%	-37.62%	238.89%
Prepaid Expenses	1.25	0.66	1.21	0.33	0.4	1.72
Total Current Assets	21.14	15.1	14.68	23.7	18.92	31.4
Other Long-Term Assets	-	0.82	0.82	-	-	-
Total Assets	21.14	15.92	15.5	23.7	18.92	31.4

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	2.46	3.01	6.28	3.85	3.52	0.51
Accrued Expenses	3.09	3.86	7.86	12.93	6.14	1.84
Short-Term Debt	0.14	0.41	0.46	-	-	-
Other Current Liabilities	0.25	-	-	0.4	0.3	-
Total Current Liabilities	5.93	7.28	14.6	17.18	9.96	2.34
Other Long-Term Liabilities	-	-	0.09	0.81	0.57	0.37
Total Liabilities	5.93	7.28	14.69	17.98	10.53	2.72

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.01	0.01	0	0	0	0
Additional Paid-In Capital	204.98	192.77	165.08	140.07	103.49	95.52
Retained Earnings	-189.78	-184.14	-164.27	-134.35	-95.09	-66.83
Total Common Equity	15.21	8.65	0.81	5.72	8.39	28.69
Shareholders' Equity	15.21	8.65	0.81	5.72	8.39	28.69
Total Liabilities & Equity	21.14	15.92	15.5	23.7	18.92	31.4

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	0.14	0.41	0.46	-	-	-
Net Cash (Debt)	19.75	14.03	13.02	23.37	18.52	29.69
Net Cash Growth	92.63%	7.79%	-44.29%	26.17%	-37.62%	238.89%
Net Cash Per Share	2.65	3.87	7.71	19.64	18.98	40.14
Filing Date Shares Outstanding	13.11	12.81	2.34	1.4	1.02	0.76
Total Common Shares Outstanding	13.11	5.87	2.33	1.4	1.02	0.72
Working Capital	15.21	7.83	0.08	6.53	8.96	29.06
Book Value Per Share	1.16	1.47	0.35	4.10	8.21	39.75
Tangible Book Value	15.21	8.65	0.81	5.72	8.39	28.69
Tangible Book Value Per Share	1.16	1.47	0.35	4.10	8.21	39.75

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 25, 2026

Data Sources Report a data error